New Key Statistics Module, Z-Score and F-Score
SZSE:301096 Key Ratios
Market Cap ¥ M | 6,787.89 |
Enterprise Value ¥ M | 6,632.66 |
P/E(ttm) | 23.52 |
PE Ratio without NRI | 21.96 |
Forward PE Ratio | -- |
Price/Book | 2.48 |
Price/Sales | 6.28 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.28 |
Revenue (TTM) ¥ M | 1,072.00 |
EPS (TTM) ¥ | 2.65 |
Beneish M-Score | -1.49 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 53.60 |
y-y EBITDA Growth Rate % | 52.90 |
EV-to-EBIT | 21.46 |
EV-to-EBITDA | 21.46 |
PEG | 0.41 |
Shares Outstanding M | 108.92 |
Net Margin (%) | 26.74 |
Operating Margin % | 29.79 |
Pre-tax Margin (%) | 29.03 |
Quick Ratio | 1.60 |
Current Ratio | 1.73 |
ROA % (ttm) | 8.17 |
ROE % (ttm) | 10.94 |
ROIC % (ttm) | 12.80 |
Dividend Yield % | 1.26 |
Altman Z-Score | 4.75 |
SZSE:301096 Number of Guru Trades
SZSE:301096 Volume of Guru Trades
Gurus Latest Trades with SZSE:301096
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301096 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Insider Transactions
No Available Data